Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Varicella-zoster virus-specific immunity after herpes zoster.

The Journal of infectious diseases - 1 Apr 1991

Hayward A, Levin M, Wolf W, Angelova G, Gilden D

Abstract excerpt

The frequency of varicella-zoster virus (VZV)-specific T lymphocytes was higher in elderly subjects who had herpes zoster infections than in age-matched controls. This increase in T cell response persisted for at least 2 years while antibody levels to VZV returned to control values at this time....

Topics

Adult
Age Factors
Aged
Aged, 80 and over
Antibodies, Viral
Herpes Zoster
Herpesvirus 3, Human
Humans
Immunization
Immunoglobulin G
Lymphocyte Activation
Middle Aged
Phenotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

T-Lymphocytes

Source

Identifiers

PMID: 1849165
DOI: 10.1093/infdis/163.4.873

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-1849165-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Varicella-zoster virus-specific immunity after herpes zoster.PMID 1849165Read ↗

Vaccination of immunocompetent elderly subjects with a live attenuated Oka strain of varicella zoster virus: a randomized, controlled, dose-response trial.Semantic proximity Read ↗

The Effect of Age on the Immunogenicity of the Live Attenuated Zoster Vaccine Is Predicted by Baseline Regulatory T Cells and Varicella-Zoster Virus-Specific T Cell ImmunitySemantic proximity Read ↗

What does epidemiology tell us about risk factors for herpes zoster?Semantic proximity Read ↗

Defective T Memory Cell Differentiation after Varicella Zoster Vaccination in Older IndividualsSemantic proximity Read ↗

Age-Related Differences In Cell-Mediated Immunity To Varicella-Zoster Virus Among Children And Adults Immunized With Live Attenuated Varicella VaccineSemantic proximity Read ↗

[Herpes zoster after varicella-zoster vaccination].Semantic proximity Read ↗

Immune response to the recombinant herpes zoster vaccine in people living with HIV over 50 years of age compared to non-HIV age-/gender-matched controls (SHINGR’HIV): a multicenter, international, non-randomized clinical trial study protocolSemantic proximity Read ↗

Breadth and Functionality of Varicella-Zoster Virus Glycoprotein-Specific Antibodies Identified after Zostavax Vaccination in HumansSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.